Updated March 31 at 10:09pm
Biotechnology
42 results total, viewing 31 - 40
Dr. Anne S. De Groot, EpiVax CEO and University of Rhode Island professor, has been named one of the most influential people in the vaccine industry by the national vaccine industry organization VaccineNation. more
Steve Lombardi has been named CEO and president of Nabsys Inc., a life sciences company pioneering semiconductor-based tools for genomic analysis. more
At a state-of-the-art facility in Thousand Oaks, Calif., drugmaker Amgen Inc. is perfecting the art of copying others. more
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the four winners of its second annual Rhode Island Bioscience Awards. more
Amgen Inc., the world’s biggest biotechnology company by sales, reported second-quarter earnings that beat analysts’ estimates and raised its profit estimate for the year. more
Mallinckrodt Plc agreed to acquire Ikaria Inc. for about $2.3 billion from a group of investors led by Madison Dearborn Partners and including New Mountain Capital LLC to expand in neonatal intensive care treatments. more
The U.S. Treasury Department has released $4.3 million, the second tranche of a $13.1 million State Small Business Credit Initiative grant awarded to Rhode Island four years ago, to support the Slater Technology Fund’s SSBCI program. more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
The Bill and Melinda Gates Foundation has awarded a $100,000 grant to the GAIA Vaccine Foundation to raise awareness about the prevention of cervical cancer in West Africa. more
Tech Collective, an industry association for information technology and bioscience, has announced a call for applicants for its 2014 Rhode Island Bioscience Awards, the program’s second year following its launch in 2013. more
« Prev | 1 | 2 | 3 | 4 | 5 Next »